Pneumococcal zinc metalloproteinase ZmpC cleaves human matrix metalloproteinase 9 and is a virulence factor in experimental pneumonia

被引:71
作者
Oggioni, MR [1 ]
Memmi, G [1 ]
Maggi, T [1 ]
Chiavolini, D [1 ]
Lannelli, F [1 ]
Pozzi, G [1 ]
机构
[1] Univ Siena, Dipartimento Biol Mol, Lab Microbiol Mol & Biotecnol, I-53100 Siena, Italy
关键词
D O I
10.1046/j.1365-2958.2003.03596.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The ZmpC zinc metalloproteinase of Streptococcus pneumoniae, annotated in the type 4 genome as SP0071, was found to cleave human matrix metalloproteinase 9 (MMP-9). The previously described IgA protease activity was confirmed to be specifically linked to the IgA1-protease/SP1154 zinc metalloproteinase. MMP-9 is a protease cleaving extracellular matrix gelatin and collagen and is activated by proteolytic cleavage like most proteases. MMP-9 is a human protease and is involved in a variety of physiological and pathological matrix degrading processes, including tissue invasion of metastases and opening of the blood-brain barrier. While TIGR4 (serotype 4) and G54 (serotype 19) pneumococcal genome strains have a highly conserved copy of zmpC, the genome of R6 (a derivative of serotype 2 D39 strain) lacks zmpC. Both the analysis for zmpC presence and MMP-9 cleavage activity in various pneumococcal strains showed correlation of ZmpC with MMP-9 cleavage activity. When assaying clinical isolates of S. pneumoniae, the zmpC gene was not found in any of the nasal and conjunctival swab isolates, but it was present in 1 out of 13 meningitis isolates and in 6 out of 11 pneumonia isolates. In a murine pneumonia model, infection with a zmpC-mutant reduced mortality at 3-4 days post-infection by 75%, when compared with infection with wild-type strains. These data indicate that the ZmpC pneumococcal protease may play a role in pneumococcal virulence and pathogenicity in the lung.
引用
收藏
页码:795 / 805
页数:11
相关论文
共 33 条
[21]   Proteolysis and cell migration: creating a path? [J].
Murphy, G ;
Gavrilovic, J .
CURRENT OPINION IN CELL BIOLOGY, 1999, 11 (05) :614-621
[22]   STEPS INVOLVED IN ACTIVATION OF THE PRO-MATRIX METALLOPROTEINASE-9 (PROGELATINASE-B)-TISSUE INHIBITOR OF METALLOPROTEINASES-1 COMPLEX BY 4-AMINOPHENYLMERCURIC ACETATE AND PROTEINASES [J].
OGATA, Y ;
ITOH, Y ;
NAGASE, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (31) :18506-18511
[23]   Comparative genomics for identification of clone-specific sequence blocks in Streptococcus pneumoniae [J].
Oggioni, MR ;
Pozzi, G .
FEMS MICROBIOLOGY LETTERS, 2001, 200 (02) :137-143
[24]   Antibiotic susceptibility and serotype distribution of Streptococcus pneumoniae causing meningitis in Italy, 1997-1999 [J].
Pantosti, A ;
D'Ambrosio, F ;
Tarasi, A ;
Recchia, S ;
Orefici, G ;
Mastrantonio, P .
CLINICAL INFECTIOUS DISEASES, 2000, 31 (06) :1373-1379
[25]  
PEARCE BJ, 2002, RES MICROBIOL, V1, P2
[26]   Role of bacterial proteinases in matrix destruction and modulation of host responses [J].
Potempa, J ;
Banbula, A ;
Travis, J .
PERIODONTOLOGY 2000, 2000, 24 :153-192
[27]   A comprehensive genetic study of streptococcal immunoglobulin A1 proteases: Evidence for recombination within and between species [J].
Poulsen, K ;
Reinholdt, J ;
Jespersgaard, C ;
Boye, K ;
Brown, TA ;
Hauge, M ;
Kilian, M .
INFECTION AND IMMUNITY, 1998, 66 (01) :181-190
[28]   Characterization of the Streptococcus pneumoniae immunoglobulin A1 protease gene (iga) and its translation product [J].
Poulsen, K ;
Reinholdt, J ;
Kilian, M .
INFECTION AND IMMUNITY, 1996, 64 (10) :3957-3966
[29]   Competence for genetic transformation in encapsulated strains of Streptococcus pneumoniae: Two allelic variants of the peptide pheromone [J].
Pozzi, G ;
Masala, L ;
Iannelli, F ;
Manganelli, R ;
Havarstein, LS ;
Piccoli, L ;
Simon, D ;
Morrison, DA .
JOURNAL OF BACTERIOLOGY, 1996, 178 (20) :6087-6090
[30]   Cleavage of a recombinant human immunoglobulin A2 (IgA2)-IgA1 hybrid antibody by certain bacterial IgA1 proteases [J].
Senior, BW ;
Dunlop, JI ;
Batten, MR ;
Kilian, M ;
Woof, JM .
INFECTION AND IMMUNITY, 2000, 68 (02) :463-469